Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19
October 26, 2023 06:45 ET
|
BioNTech SE
Lead formulations evaluated in the Phase 1/2 study demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains Safety profile of the mRNA-based combination vaccine...
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 24, 2023 09:49 ET
|
GreenLight Biosciences
LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced the closing of its previously announced...
mRNA Vaccines and Therapeutics Market Size is projected to reach USD 58.92 billion by 2031, growing at a CAGR of 13.3%: Straits Research
June 08, 2023 11:00 ET
|
Straits Research
New York, United States, June 08, 2023 (GLOBE NEWSWIRE) -- mRNA-based therapeutics and vaccines permit the combination of desirable immunological properties. These are manufactured in the laboratory...
mRNA Vaccines And Therapeutics Global Market to Show Decline in Growth at a CAGR of ~-34% by 2028 | DelveInsight
May 23, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 23, 2023 (GLOBE NEWSWIRE) -- mRNA Vaccines And Therapeutics Global Market to Show Decline in Growth at a CAGR of ~-34% by 2028 | DelveInsight The rising demand for protection...
Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients
March 23, 2023 07:55 ET
|
Evaxion Biotech
Evaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapy This potentially enables treatment for patients with cold tumors, normally unresponsive to...
Evaxion and Pantherna announce promising preclinical mRNA vaccine data
February 08, 2023 06:30 ET
|
Evaxion Biotech
COPENHAGEN, Denmark and HENNIGSDORF, Germany, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing...
mRNA therapeutics and mRNA vaccines market is anticipated to grow at a steady pace, till 2035, claims Roots Analysis
February 01, 2023 10:30 ET
|
Roots Analysis
London, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “mRNA Therapeutics and mRNA Vaccines Market, 2022–2035” report to its list of offerings. The mRNA...
The mRNA synthesis and mRNA manufacturing market is projected to be worth USD 1.5 billion by 2035, claims Roots Analysis
January 26, 2023 11:25 ET
|
Roots Analysis
London, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “mRNA Synthesis and mRNA Manufacturing Services Market (2nd Edition), 2022–2035” report to its list of...
Global mRNA Vaccines Market Size – Forecasts to 2028
January 10, 2023 09:15 ET
|
Global Market Estimates
Brooklyn, New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global mRNA Vaccines Market is projected to grow at a CAGR...
Update on First BioNTainer for African-based mRNA Manufacturing Facility
December 21, 2022 08:45 ET
|
BioNTech SE
MAINZ, GERMANY, December 21, 2022 — BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone in the establishment of scalable mRNA vaccine production in Africa. The six ISO-sized shipping...